Development Of An On-Chip Binding Assay To Select Clones Producing High Quality Bispecific Antibodies

Join Dr. Shu Wang, a leading expert in the field, as he delves into the innovative development of an on-chip binding assay for selecting top-tier clones for bispecific antibody production. This groundbreaking approach, developed in collaboration with Bruker Cellular Analysis, dramatically improves satellite development efficiency and reduces false negatives.

Key Highlights:

• Cell Line Development Made Easy: Discover how this cutting-edge assay streamlines the process of selecting the best clones from beaker pools.
• Enhanced Antibody Quality: Learn how this technology ensures the production of high-quality antibodies, essential for therapeutic applications.
• Behind the Scenes: Get a glimpse into the collaborative research efforts and the advanced techniques used in this project.

Don't miss this opportunity to gain valuable insights into the future of antibody development. Watch the presentation now to learn more.